Organon & Co
719 hedge funds and large institutions have $2.86B invested in Organon & Co in 2023 Q4 according to their latest regulatory filings, with 134 funds opening new positions, 188 increasing their positions, 280 reducing their positions, and 136 closing their positions.
0.31% less ownership
Funds ownership: 77.8% → 77.49% (-0.31%)
1% less first-time investments, than exits
New positions opened: 134 | Existing positions closed: 136
2% less funds holding
Funds holding: 730 → 719 (-11)
11% less call options, than puts
Call options by funds: $39.8M | Put options by funds: $44.6M
17% less capital invested
Capital invested by funds: $3.45B → $2.86B (-$597M)
33% less repeat investments, than reductions
Existing positions increased: 188 | Existing positions reduced: 280
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$242M |
| 2 |
SPC
Slate Path Capital
New York
|
+$48.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$43.3M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$40.6M |
| 5 |
Morgan Stanley
New York
|
+$38.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$223M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$116M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$87.3M |
| 4 |
State Street
Boston,
Massachusetts
|
-$58.2M |
| 5 |
Amundi
Paris,
France
|
-$32.1M |
OGN Hedge Fund Activity: Q4 2023 in Review
719 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2023, worth a combined $2.86B — down 17% from $3.45B a quarter earlier.
Sellers outnumbered buyers: 136 funds closed out of OGN and 134 opened new positions — a net loss of 2 holders — while 280 trimmed existing stakes and 188 added.
The largest buyer was BlackRock, adding an estimated $242M. The largest seller was Mawer Investment Management, exiting entirely with an estimated $223M sold.
- 719 institutional investors held Organon & Co (OGN) as of Q4 2023, down from 730 in Q3 2023.
- Funds reported $2.86B of Organon & Co stock for Q4 2023, down 17% quarter-over-quarter.
- 134 funds opened new Organon & Co positions in Q4 2023 and 136 closed out, a net change of -2 holders.
- The largest Organon & Co buyer in Q4 2023 was BlackRock, an estimated $242M added.
- The largest Organon & Co seller in Q4 2023 was Mawer Investment Management, an estimated $223M sold.
Based on aggregated 13F filings for Q4 2023.